Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Oct 14 04:00PM ET
233.22
Dollar change
+3.96
Percentage change
1.73
%
IndexS&P 500 P/E30.25 EPS (ttm)7.71 Insider Own0.82% Shs Outstand181.50M Perf Week3.49%
Market Cap42.52B Forward P/E18.76 EPS next Y12.43 Insider Trans-0.09% Shs Float180.80M Perf Month-2.30%
Income1.42B PEG2.68 EPS next Q2.81 Inst Own93.40% Short Float1.71% Perf Quarter0.11%
Sales15.16B P/S2.80 EPS this Y9.63% Inst Trans3.63% Short Ratio2.85 Perf Half Y0.89%
Book/sh36.83 P/B6.33 EPS next Y11.15% ROA5.43% Short Interest3.09M Perf Year18.02%
Cash/sh9.20 P/C25.34 EPS next 5Y11.28% ROE22.84% 52W Range167.42 - 261.73 Perf YTD0.80%
Dividend Est.- P/FCF23.27 EPS past 5Y42.42% ROI7.49% 52W High-10.89% Beta1.50
Dividend TTM- Quick Ratio0.85 Sales past 5Y7.76% Gross Margin27.57% 52W Low39.30% ATR (14)5.12
Dividend Ex-Date- Current Ratio0.85 EPS Y/Y TTM32.25% Oper. Margin13.88% RSI (14)48.33 Volatility1.86% 2.02%
Employees87000 Debt/Eq2.00 Sales Y/Y TTM3.45% Profit Margin9.39% Recom1.56 Target Price273.19
Option/ShortYes / Yes LT Debt/Eq1.83 EPS Q/Q23.81% Payout0.00% Rel Volume0.63 Prev Close229.26
Sales Surprise0.65% EPS Surprise2.94% Sales Q/Q2.53% EarningsJul 22 BMO Avg Volume1.09M Price233.22
SMA20-0.40% SMA50-2.34% SMA2000.49% Trades Volume683,108 Change1.73%
Date Action Analyst Rating Change Price Target Change
Oct-14-24Initiated Redburn Atlantic Buy
Sep-04-24Initiated RBC Capital Mkts Outperform $275
Jul-24-24Downgrade Jefferies Buy → Hold $266 → $242
Jun-06-24Initiated Goldman Buy $270
Feb-26-24Initiated Leerink Partners Outperform $290
Feb-15-24Downgrade Guggenheim Buy → Neutral
Feb-13-24Initiated BTIG Research Buy $285
Nov-02-23Downgrade Robert W. Baird Outperform → Neutral $248 → $202
Sep-06-23Initiated HSBC Securities Buy $260
Mar-17-23Initiated Truist Buy $265
Oct-04-24 09:40AM
Oct-02-24 09:00AM
Sep-25-24 06:20PM
08:26AM
Sep-19-24 09:00AM
09:40AM Loading…
Sep-17-24 09:40AM
01:12AM
Sep-13-24 01:41PM
Sep-12-24 09:50AM
Sep-04-24 02:23PM
09:00AM
Aug-29-24 06:24PM
Aug-21-24 04:15PM
11:30AM
Aug-16-24 10:09AM
09:45AM Loading…
Aug-14-24 09:45AM
Jul-31-24 04:13PM
Jul-29-24 09:15AM
Jul-25-24 06:18PM
Jul-24-24 03:26AM
Jul-23-24 09:40AM
01:49AM
01:00AM
Jul-22-24 06:30PM
04:28PM
01:47PM
11:25AM
10:37AM
08:15AM
07:11AM
07:00AM Loading…
07:00AM
Jul-17-24 11:00AM
Jul-16-24 06:28PM
Jul-12-24 06:02AM
Jul-11-24 08:30AM
Jul-08-24 04:15PM
Jul-01-24 08:01AM
Jun-25-24 08:00AM
Jun-18-24 08:49AM
06:13AM
Jun-13-24 12:23PM
04:32AM
Jun-12-24 08:00AM
Jun-10-24 08:00AM
Jun-06-24 03:07PM
Jun-03-24 06:28PM
May-28-24 06:04AM
May-24-24 11:17AM
May-14-24 08:00AM
May-09-24 04:15PM
May-07-24 06:49AM
May-04-24 09:27AM
May-03-24 12:11PM
11:49AM
11:17AM
11:00AM
10:07AM
09:43AM
09:40AM
09:31AM
08:11AM
07:09AM
03:32AM
01:05AM
12:13AM
May-02-24 11:55AM
11:47AM
10:12AM
08:10AM
08:04AM
07:11AM
07:00AM
May-01-24 04:30PM
Apr-29-24 10:26AM
09:16AM
Apr-25-24 11:34AM
10:02AM
Apr-24-24 12:34PM
Apr-23-24 09:00AM
Apr-18-24 05:00PM
Apr-17-24 12:00PM
Apr-15-24 04:15PM
Apr-08-24 04:01PM
07:41AM
Apr-04-24 09:40AM
09:08AM
Apr-02-24 11:39AM
Mar-20-24 07:44PM
Mar-15-24 01:38PM
11:30AM
Mar-13-24 12:07PM
Mar-06-24 04:15PM
Feb-27-24 08:00AM
Feb-26-24 08:00AM
Feb-23-24 09:00AM
Feb-21-24 04:15PM
Feb-16-24 12:02AM
Feb-15-24 05:34PM
10:39AM
01:30AM
IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. It operates through the following segments: Technology and Analytics Solutions, Research and Development Solutions, and Contract Sales and Medical Solutions. The Technology and Analytics Solutions segment supplies mission critical information, technology solutions, and real-world solutions and services to the firm's life science clients. The Research and Development Solutions segment provides outsourced clinical research and clinical trial related services. The Contract Sales and Medical Solutions segment offers health care provider and patient engagement services to both biopharmaceutical customers and the healthcare market. The company was founded by Dennis B. Gillings and Gary Koch in 1982 and is headquartered in Durham, NC.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sherbet EricSee RemarksAug 27 '24Sale246.331,300320,22919,536Aug 29 05:02 PM
Sherbet EricOfficerAug 27 '24Proposed Sale246.331,300320,229Aug 27 05:23 PM
BOUSBIB ARISee RemarksMar 01 '24Option Exercise65.1642,8472,791,911828,430Mar 04 05:28 PM
BOUSBIB ARISee RemarksMar 01 '24Sale250.5331,6787,936,193796,752Mar 04 05:28 PM
STAUB W RICHARDSee RemarksFeb 29 '24Sale247.8014,1003,494,03415,945Mar 04 05:27 PM
Knightly Kevin CSee RemarksFeb 28 '24Option Exercise87.4013,2061,154,21113,858Mar 01 05:07 PM
Knightly Kevin CSee RemarksFeb 28 '24Sale250.178,6072,153,1765,251Mar 01 05:07 PM
Sherbet EricSee RemarksFeb 16 '24Sale241.501,000241,50020,836Feb 21 05:08 PM
Knightly Kevin CSee RemarksFeb 16 '24Option Exercise78.2112,149950,17318,061Feb 21 05:07 PM
Knightly Kevin CSee RemarksFeb 16 '24Sale241.1013,4683,247,165652Feb 21 05:07 PM
Knightly Kevin CSee RemarksDec 01 '23Option Exercise62.2618,4911,151,18520,464Dec 05 05:01 PM
Knightly Kevin CSee RemarksDec 01 '23Sale214.0313,1172,807,4727,347Dec 05 05:01 PM